Michael Cooperman
Internal Medicine · Melrose Park, PANPI 1972568244
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,190 of the $40,429 with a category attached, or 79.6%. Merck accounts for 81.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $34,163 and has fallen 97.0% since, to $1,014 in 2022. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $89.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$33K
- Johnson & Johnson$2K
- Lilly USA, LLC$1K
- Sanofi-aventis U.S. LLC$967
- AstraZeneca$555
- Novo Nordisk$515
- plus $2K from 12 others
Across 4 payments — averaging $294.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1K
What the payments were for
- Speaking & faculty fees$32,19080%
- Travel & lodging$2,0095%
- Food & beverage$6,15015%
- Education$200%
- Gifts$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 74 | $33,001 |
| Johnson & Johnson | 9 | $2,236 |
| Lilly USA, LLC | 80 | $1,192 |
| Sanofi-aventis U.S. LLC | 65 | $967 |
| AstraZeneca | 31 | $555 |
| Novo Nordisk | 37 | $515 |
| Mannkind Corporation | 56 | $513 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $360 |
| Boehringer Ingelheim | 21 | $311 |
| Xeris Pharmaceuticals, Inc. | 15 | $213 |
| Corcept Therapeutics | 13 | $204 |
| AbbVie | 11 | $155 |
| Abbott | 6 | $112 |
| Medtronic | 3 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| BD | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,429 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 14 | $3,845 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Melrose Park
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.